FDA closes inspection of Strides Pharma’s Bangalore unit
The USFDA has closed an inspection of India’s Strides Pharma Science in southern Bangalore, which serves markets in the US, Europe and Australia,.
Drugs
Pharma
Drugs
Health
Pharma
Stelis Biopharma to be pure play CDMO firm, may list ‘near term’
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.